The Urgency of Unmet Cancer Needs: Key Driver Behind the $13.61 Billion Projected Valuation of NK Cell Therapeutics.
The most profound driver of the **Natural Killer (NK) Cell Therapeutics Market’s** dramatic growth is the pervasive global challenge of **unmet medical needs** in oncology. Despite advancements in chemotherapy, radiation, and even first-generation immunotherapies, a significant portion of cancer patients still fail to respond to standard treatments, experience debilitating side effects,...
0 Комментарии 0 Поделились 67 Просмотры 0 предпросмотр